Aniket Bankar

Toronto, ON M5G2M9, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Impact of High-Risk Mutations and Treatment Intensity in Accelerated-Phase Blast-Phase MPN Without Adverse-Risk Karyotype and TP53.

Impact of High-Risk Mutations and Treatment Intensity in Accelerated-Phase Blast-Phase MPN Without Adverse-Risk Karyotype and TP53.

Journal: Current oncology (Toronto, Ont.)
Published: May 05, 2026

Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT.

Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT.

Journal: Current oncology (Toronto, Ont.)
Published: January 06, 2026

Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada.

Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada.

Journal: British journal of haematology
Published: December 03, 2025

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

Journal: Clinical lymphoma, myeloma & leukemia
Published: September 18, 2025

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.

Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique
Published: September 02, 2025

Title Not Found

Title Not Found

Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique
Published: August 28, 2025

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving.

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving.

Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique
Published: August 28, 2025

Clinical decisions in clonal hematopoiesis: a contemporary review for clinicians.

Clinical decisions in clonal hematopoiesis: a contemporary review for clinicians.

Journal: Haematologica
Published: August 27, 2025

Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention.

Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention.

Journal: Haematologica
Published: June 25, 2025

Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial.

Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial.

Journal: The Lancet. Haematology
Published: May 23, 2025

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Journal: Blood cancer journal
Published: April 21, 2025

Identifying Risk Factors and Outcome for CNS Involvement in AML.

Identifying Risk Factors and Outcome for CNS Involvement in AML.

Journal: Clinical lymphoma, myeloma & leukemia
Published: April 07, 2025
Showing 1-12 of 34

Last Updated: 09/26/2026